Stéphane Ferretti

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

Medicine, Oncology, Pharmacology +12

IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger

Stéphane Ferretti, Olivier Bonneau, Gerald Dubois et al. · The Journal of Immunology · 2003 · 535 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

Christine Fritsch, Alan Huang, Christian Chatenay‐Rivauday et al. · Molecular Cancer Therapeutics · 2014 · 496 citations

Medicine, Oncology, Pharmacology +16

Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors

Philipp Holzer, Keiichi Masuya, Pascal Furet et al. · Journal of Medicinal Chemistry · 2015 · 206 citations · Full text

Medicine, Oncology, Pharmacology +15

M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth

Marta Cortés-Cros, Christelle Hemmerlin, Stéphane Ferretti et al. · Proceedings of the National Academy of Sciences · 2012 · 161 citations · Full text

Life Sciences, Biochemistry, Oncology +17